Loading organizations...
§ Venture Capital · 372 Depot St., Suite 30, Asheville, NC, 28806
Equity investment firm providing capital and strategic value for early-stage companies, focused on healthcare and energy sectors.
JACS Capital provides equity investments in early-stage companies, primarily focusing its thematic capital deployment within the critical healthcare and evolving energy sectors. The firm's investment philosophy extends beyond financial contributions, placing significant emphasis on the strategic value it can bring to its portfolio companies, rigorously evaluating the founder's vision, the strength of the management team, and the originality of the core idea as paramount factors in its investment decisions. While specific financial metrics, including assets under management or detailed portfolio valuations, are not publicly disclosed, the firm actively seeks to identify and nurture high-potential ventures. Chris Renno is a notable representative associated with JACS Capital, often articulating the firm's strategic outlook and engagement model. The organization's commitment is to foster long-term growth and impactful innovation within its specialized industry verticals; however, information regarding JACS Capital's founding year and its specific founders is not publicly available.
JACS Capital has 2 tracked investments across 2 companies. The latest tracked deal is $100.0M Series B in Cambium in January 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 5, 2026 | Cambium | $100.0M Series B | JOE Lonsdale | Jackson Moses, Alumni Ventures, Gaingels, Gsbackers, Inevitable Ventures, J17 Capital, Lockheed Martin Ventures, MVP Ventures, Vanderbilt University, Veteran Ventures |
| Nov 14, 2025 | ElectronX | $30.0M Series A | ALI Tamaseb | Equinor Ventures, Five Rings, GTS, Innovation Endeavors, NGP, Shell Ventures, Systemiq Capital, XTX Ventures |